Biotech companies are spending billions to perfect chemical formulas, only to be tripped up by the one variable they forgot ...

Analysts have given Alnylam Pharmaceuticals an average price target of $436.

Seven life sciences companies cut at least 346 jobs in Massachusetts between April and June, with some of the layoffs tied to ...

David Craig’s operating manual for building biotech companies in today’s market is now available in hardcover and as an ...

Biotech pioneer Genentech will cut 103 jobs in its latest round of layoffs, including its head of cell therapy and 33 ...

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.

It has been a banner year for biotech buyouts, and these are two of the prime targets.

Sofinnova Investments’ Jim Healy says biotech innovation is thriving but is skeptical about artificial intelligence’s ability ...

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...

IBB, one of the largest exchange-traded funds focused on biotechnology, manages approximately $8.28 billion in assets and ...

Biotech and biopharma companies choose names that cluster around certain letters in the alphabet - here's what they are, and ...